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Approved for Public Release; Distribution Unlimited 13. ABSTRACT (Maximum 200 Words) We have filly characterized the expression and localization of claudin 7 in the mammary epithelium, finding that it is not associated with tight junctions but is constitutively present in punctate structures, presumably vesicles, at the basal and lateral borders of cells. The same is true of bronchiole and certain elements of the renal epithelium while claudin 7 is found associated with tight junctions of the epididymus and mouse mammary cell lines. Four types of murine mammary tumors were examined. In all claudin 7 showed a distinct cytosolic and basolateral distribution. We find claudins 1, 3, 4, 5, 7 and 8 to be present in at least one of our mouse mammary cell lines, where they are localized to the tight junction. Only claudin 1 has been found to be consistently present in mammary epithelial tight junctions. Claudin 3 is localized to the basal and lateral borders of the cells in the virgin and pregnant animals, but not observed in lactation. Claudin 8 is prominent at the tight junctions in the mammary epithelium from the lactating animal. One paper has been submitted detailing these findings and a second is in the final stages of preparation.
INTRODUCTION
The purpose of the research funded under the above research grant was to examine the hypothesis that the gene for the tight junction protein, claudin-7, plays a role in breast cancer. We planned to test the hypothesis that high expression of claudin-7 can signify one or more novel roles in tumorigenesis by:
1. Determining the cellular and subcellular localization of claudin-7 in the mouse mammary gland.
2. Comparing mRNA levels of claudin-7 to claudin-1, claudin-3 and two adherens proteins, E-cadherin and beta-catenin.
3. Examining the functional significance of claudin-7 by overexpressing it in cell lines and in the mammary gland.
Objective 1, which comprises TASKS 1, 2 and 3 in the statement of work was completed in the first year. In the intervening two years we refined our immunocytochemical analysis to show that claudin 7 is not only a constitutive component of the mammary luminal epithelium but is present solely at the basal-lateral borders of the cell and does not overlap the tight junctions. It appears both to be present in the membranes and in vesicles near the membrane. These data have been written up for publication and a .pdf of the submitted document is attached. Objective 2, which comprises parts of tasks 5 and 6 was largely completed based on microarray analysis last year. In addition we examined claudins 1-6 and 8 in more detail, using antibodies to obtain localization of these molecules. Details of the localization of some of these claudins will be presented in this report Objective 3 was changed to examine the functional significance of claudins. Because we have found significant changes in claudins 3 and 8, we have cloned these molecules and plan to use them in expression studies in the normal gland. This task is still ongoing.
We spent much time determining the specificity of the available claudin antibodies and have found this to be a particularly difficult task, as many of the antibodies available, particularly those from Santa Cruz, do not work as advertised. The criteria we use for antibody specificity are:
1. The antibody shows localization to the tissue in which it has been demonstrated by previous investigators and does not stain tissues that have been shown to be negative by immunohistochemistry or Northern analysis.
2. Localization to tight junctions by immunohistochemistry in mouse mammary cell lines that form tight junctions in vivo, either EPH4 cells or CIT3 cells.
3. Blocking by incubation with the specific peptide against which the antibody has been made.
We will start the report by summarizing the results of our studies on claudin-7 and then summarize our progress with the other claudins in the 1 to 8 series.
BODY:
1. Claudin-7 localization in the mammary epithelial cell.
Our PCR studied showed that Figure 1 . Mouse epididymis stained with claudin-7 is a constitutive antibodies to claudin 7 and the tight component of mammary junction protein ZO-1. Note the overlap epithelial cells at all stages of between Claudin 7 and ZO1 staining in the mammary development and merged image (Yellow) . that it is also present in mammary tumors. We had an antibody made by Zymed and showed that it cross reacts with the protein on Western blots (TASK 4) , stains only the luminal epithelium in sections of mouse mammary gland, stains tight junctions in EPH4 cells ( Figure 5 ) and reacts with bronchiole epithelial cells, accounting for detection of the mRNA in the lung (1) but not with cells in the liver where it is not present by mRNA analysis. The antibody stains both frozen and paraffin sections. Staining is blocked by the peptide against which the antibody was made and was not seen in the absence of antibody. All these criteria indicate that the antibody is specific for claudin-7. This year we have additional data showing that the protein does localize to tight junctions the epididymus ( Figure 1 ). Note that the stain in the upper panel coincides at least in part with the cobblestone stain in the second panel indicating overlap at the tight junctions in this tissue, where there also appears to be cytoplasmic stain. However, Claudin 7 appears to be completely excluded from the tight junctions of mammary epithelial cells as shown by the data in Figures 2 and 3 . The higher power view in Figure 3 shows that the stain is punctate in nature suggesting a vesicular localization near the borders of the cell. This significance of this localization is not known at this point. It is however, one of very few documented instances where the claudin doesn't localize to the tight junction. A. Real time RT-PCR measurement of claudin 7 and keratin 19 from total mammary glands of non-pregnant non-lactating (NPNL) mice, mice at 5, 12, and 18 days of pregnancy (P5, P12, P18) and 2, 10, 19,22 and 29 days post partum (L2, L10, L19, L22, L29). By L29 the pups have weaned themselves and mammary gland involution is nearly complete. Dotted line: Ratio of claudin-7 RNA to Keratin 19 at the same time points. Three mice analyzed at each time point. Bars are ± 1 s.e.m. Where no bar is apparent, the standard deviation falls within the symbol. Asterisks indicate points that differ significantly from values at L2, p < 0.05. B. In situ hybridization of claudin 7 probes to sections from virgin, pregnant and lactating mammary glands. Sections labeled A were hybridized to the antisense probe; the lower right hand section labeled S is the sense control. Bar is 20 microns.
We used real time PCR to CLAUDINS examine the expression of claudin 7, comparing its expression to that of U keratin 19, a marker for mammary epithelial cells. CLDN 
3
CLAtDIN 8 Its expression paralleled .N that of keratin 19 throughout the developo mental cycle of the where the RNA was found Figure 5 . Microarray data for developmental regulation of claudin associated only with the expression in the mammary gland from the virgin (V) through mammary epithelium. We pregnancy days 1, 3, 7, 12 and 17, lactation days 1, 2 and 9 and two then expanded our days of forced involution after pup removal at day 9 (12).
6 microarray analysis of mammary gland claudins during normal development. Figure 5 shows the expression of claudins I through 8 in the mammary epithelium in a developmental series that used 4 animals for every point compared to GAPDH expression. Claudin 3 increases through pregnancy dropping off sharply with the onset of lactation. Claudin 8, on the other hand, is highly expressed during pregnancy. Claudins 4 and 5 also appear to be developmentally regulated. Claudins 1, 2 and 6 are expressed at very low levels and we have, of course, already described the expression of claudin 7 (above and last years progress report). We procured antibodies to all these claudins to determine whether the protein was expressed and its localization. Table 1 and the paragraphs below summarize our progress in this regard.
3. Immunohistochemical staining for Claudins 1-6 and 8 in the mammary gland. Claudin 1. Although claudin 1 gene expression is low we did find claudin 1 localized to tight junctions at all stages of development. Figure 5 shows results from the virgin mouse, but similar observations were made in pregnancy and lactation. Interestingly the stain is concentrated at the junction but extends beyond the junction in a way that suggests that it may be trafficking to or from the junction in vesicles. This was a common finding in all preparations where claudins were observed at tight junctions. .,
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Claudin 2. We were unable to find stain for claudin 2 in any of the mammary tissues or cell lines observed. We have not yet verified the positive control for this claudin so it may be that the antibody is not working on our sections.
Claudin 3. Claudin 3 gene expression increases markedly at mid pregnancy with a sharp decline at the onset of lactation. Although claudin 3 stained tight junctions in EPH4 cells (data not shown) it was distributed at the basal and lateral borders of mammary epithelial cells from virgin and pregnant mice. Figure 7 shows that this claudin is distributed at tight junctions in EPH4 cells suggesting that the antibody does indeed stain for a claudin. Figure 8 shows a paraffin section of a mammary gland from a pregnant mouse. ZO I (green) shows a clear lattice work at the apical borders of the cell but claudin 3 stain (red) does not overlap with ZO-1 but is confined to the cytoplasm. No claudin 3 stain was observed in lactating mice. The implications of its cytosolic expression in pregancy are not clear. It will be of interest to determine whether this pattern is repeated in mammary tumors as it is for claudin 7. Claudin 4. From the array data, claudin 4 was present at pregnancy but absent at lactation, increasing again at involution in mammary tissue. This finding has been confirmed by real time PCR. The antibody showed positive staining at tight junctions in both EPH4 and CIT3 cells, However, there was no stain in the mammary epithelium although there appeared to be some interstitial stain which could represent blood vessels.
Claudin 5. Gene expression was low in pregnancy and lactation but increased at involution. Tight junction stain was observed in both EPH4 and CIT3 cells, but no stain was observed in either the pregnant or lactating gland. We have not yet examined involution.
Claudin 6. Gene expression was very low at all stages of mammary development and we were unable to detect any stain in either cultured cells or mammary epithelium. The positive control has yet to be done for this claudin and the antibody may be suspect because it came from Santa Cruz. The remainder of our antibodies are from Zymed, a company we have found to be more reliable Claudin 8. Claudin 8 is the most interesting of the claudins examined to this point. Its gene expression is low through pregnancy with a sharp increase at lactation. We detected the protein, using a purpose made antibody from Zymed, at the tight junctions of CIT3 cells but not in EPH4 cells. We did not detect stain in virgin tissue. Occasional tight junctions were stained in the pregnant animal, whereas stain was consistently observed at tight junctions in the lactating animal ( Figure 8 ). This finding is exciting because claudin 8 has been associated with reduced permeability in cultures of MDCK cells (1) . We have previously reported that claudin 8 mRNA is present in mammary tumors, but we have not yet examined these tumors for the presence and localization of the protein. KEY RESEARCH ACCOMPLISHMENTS since the beginning of the grant.
A specific and highly active antibody to claudin 7 has been developed and shown to react with claudin 7 on Western blots (tasks l and 4). Claudin-7 is localized to luminal epithelial cells in the mammary gland throughout development by in situ hybridization and specifically to the basolateral membranes of these cells in both normal glands and mammary tumors as shown by immunohistochemistry (Task 2). This claudin is present at tight junctions in cultured cells and epidymus, but not in lung or mammary epithelium. A submitted paper detailing our findings with claudin 7 has been submitted (see appendix)
The developmental expression of claudin-7 mRNA was shown to parallel expression of keratin by real time RT-PCR and high expression was found in a series of tumors (Task 3). * Expression of additional claudins and claudin-like molecules has been quantitated by microarray analysis using Affymetrix arrays (Task 5). The expression of claudin 8 has been confirmed by real time RT-PCR and found to increase more than 10 fold at lactation. The protein was found in the tight junctions of the mammary epithelium only in the lactating gland. * Claudin 8 is expressed in mammary tumors although they lack tight junctions. (Task 5).
• Claudins I has been localized to tight junctions in mammary epithelial tissues throughout development ( Task 5) . Claudins 3, 4, 5, and 8 were observed at tight junctions in mammary cell lines. However, claudin 8 was the only one of these associated with the mammary tissue tight junction, and then only at lactation. Claudins 2 and 6 were not observed in any mammary epithelium.
II

REPORTABLE OUTCOMES.
A paper describing the use of adenoviral transduction to express foreign genes in the mammary epithelium has been published in J. Virol. (Appendix). This study was started with the support of a previous DOD breast cancer grant and was completed in the project period of the present grant.
A paper describing our findings with claudin 7 has been submitted (Manuscript in appendix)
A paper describing the expression and localization of claudins during mammary development will be submitted to J. Physiol. We have now fully characterized the expression and localization of claudin 7 in the mammary epithelium, finding that it is not associated with tight junctions but is constitutively present in punctate structures, presumably vesicles, at the basal and lateral borders of cells. We find the same to be true of mouse mammary tumors. We are now in the process of fully characterizing the expression of claudins 1 through 6 and claudin 8 in the developing mammary epithelium and in mammary cell lines. We find claudins 1, 3, 4, 5 and 8 to be present in at least one of our mouse mammary cell lines, where they are localized to the tight junction. However, only claudin 1 has been found to be consistently present in mammary epithelial tight junctions. Claudin 3 is localized to the basal and lateral borders of the cells in the virgin and pregnant animals, but not observed in lactation. Claudin 8 is prominent at the tight junctions in the mammary epithelium from the lactating animal but not at other developmental stages suggesting it may participate in the closure of tight junctions observed during lactation.
These studies are important because they set the stage for more detailed examination of the function of the claudins in both the normal mammary gland through development and breast tumors. The finding of the basolateral localization of claudin 7 is particularly intriguing for it may be involved with interactions of vesicular components of the cells with basolateral elements and may contribute to stable cell-stroma interactions.
Because the mammary parenchyma is accessible from the exterior of an animal through the mammary duct, adenovirus transduction holds promise for the short-term delivery of genes to the mammary epithelium for both research and therapeutic purposes. To optimize the procedure and evaluate its efficacy, an adenovirus vector (human adenovirus type 5) encoding a green fluorescent protein (GFP) reporter and deleted of El and E3 was injected intraductally into the mouse mammary gland. We evaluated induction of inflammation (by intraductal injection of [" 4 C]sucrose and histological examination), efficiency of transduction, and maintenance of normal function in transduced cells. We found that transduction of the total epithelium in the proximal portion of the third mammary gland varied from 7% to 25% at a dose of 2 x 106 PFU of adenovirus injected into day 17 pregnant mice. Transduction was maintained for at least 7 days with minimal inflammatory response; however, significant mastitis was observed 12 days after transduction. Adenovirus transduction could also be used in the virgin animal with little mastitis 3 days after transduction. Transduced mammary epithelial cells maintained normal morphology and function. Our results demonstrate that intraductal injection of adenovirus vectors provides a versatile and noninvasive method of investigating genes of interest in mouse mammary epithelial cells.
The mammary gland is a compound lobulotubular structure tible to tumorigenesis (13), it would be desirable to be able to that is a reliable model for developmental studies of cellular manipulate its genetic complement at different developmental growth and differentiation, epithelium-stroma interactions, stages and study the effects of these changes. For this reason, and tissue-level analysis of systemic hormonal regulation (13).
we investigated the utility of adenovirus transduction in \ivo to In humans, it begins to develop in the 18-to 19-week fetus and alter gene expression by using injection through the nipple to after birth remains quiescent until puberty, when hormonal gain access to the epithelium from the exterior of the animal. stimulus by estrogen and growth hormone triggers the tree-like Earlier investigators have taken advantage of intraductal inbranching of a network of ducts that extends from the nipple jection techniques, using injections in goats and mice to study into the mammary fat pad on the anterior wall of the thorax the permeability of the mammary epithelium to Na', C0 , and (12, 13). Lobular structures, which will become the milk-seradiolabeled sucrose (8, 16 ). creting acini, originate from these ducts. Lobular development DEAE-dextran-mediated transfection has been used to obis highly dependent upon hormonal stimulation, and in hutain human growth hormone expression in the guinea pig mans. in whom these lobular structures are known as terminal mammary gland after intraductal injection (5). However, the duct lobular units, begins after the onset of menses. In mice the proportion of transfected cells was quite low. On the other extent of lobular development in the virgin animal is strain hand, adenovirus transduction has proven to be a suitable dependent (12). Full alveolar development and maturation of method for efficient transduction of primary mammary cells in the mammary epithelium take place during pregnancy and are vitro in combination with mammary gland reconstitution to dependent upon high circulating concentrations of progesteryield highly efficient gene transfer (18). In vivo, Jeng and coone, prolactin, and/or placental lactogen (12). Upon withworkers injected an adenovirus vector coding for P-galactosidrawal of progesterone at parturition, lactation commences.
dase into the rat mammary gland through the mammary duct Ongoing milk secretion continues during lactation under the and obtained significant expression of the gene (6). Yaii, ci al.
intluence of prolactin and oxytocin and ceases at weaning.
(24) obtained expression of LacZ in the mouse mammary When regular extraction of milk ceases, the alveolar epitheglain eri d nion of an adenous veelium undergoes apoptosis and remodeling, and the gland regland in vivo after intraductal injection of an adenwirus vccverts to a prepubertal stage (12).
tor. Although these studies demonstrated the effectiveness of Since the mammary gland undergoes its functional morphoadenovirus vectors, the issues of an inflammatory response and genesis in the young adult to adult stages and is very suscepthe efficiency of transduction have not been fully addressed.
We are primarily interested in the transition from pregnancy to lactation and sought a noninvasive, noninflammatory delivCorresponding author. Mailing address: Department of Microbi ery system for introducing foreign genes into the mammary ology. Box B 175, Room 4617, University of Colorado Health Sciences epithelium without transduction of the surrounding stroma. Center, Denver, CO 80262. Phone: (303) pregnancy most carefully, we also present data obtained at other stages of mammary gland development.
gland as previously described (14). To evaluate the reliability ot the injection MATERIALS AND METHODS technique, sterile filtered Ringer's solution was injected into contralatcral control glands in some experiments. Animals. CD-I mice aged 5 to 9 weeks were purchased from Charles River Determination of mammary epithelium permeability. Since increased I "ClstuBreeding ILaboratory (Wilmington, Mass.) and maintained in the U.S. Departcrose permeability is one of the hallmarks of mastitis (9), we used this isotope to ment of Agriculture-approved Center for Laboratory Animal Care of the Unidetermine mammary epithelium permeability. On the day of sacrifice, 2 tCi ot versity of Colorado Health Sciences Center Animal Care Facility. Nulliparous, [ t "Csucrose (Amersham, Buckinghamshire, United Kingdom) were lyophilized early pregnant (3 days; P3), late pregnant (17 days; P17), and lactating (4 days and dissolved in sterile Ringer's solution. Then 5 pA (nulliparous glands). 40 ptl postparturition; tA) mice were used in this study. Pregnancies were timed by (fourth mammary glands), or 20 Wd (third mammary glands) of this solution was observing a vaginal plug (day I of pregnancy) after overnight residence with a injected intraductally into the lumens of adenovirus-injected and contralateral stale. The due date was calculated as 19 days after observation of the vaginal control mammary glands of each mouse under avertin anesthesia. '1te 10-RiI plug. Mice were housed under a 12-h light-12-h dark cycle and maintained on blood samples were taken from the tail vein 5 min after each injection, and the either breeder\s chow (Teklad S-2335, no. 7014 mouse breeder diet; Harlan amount of t"C present was determined by liquid scintillation counting. Icklad. Madison, Wis.) or a standard diet for posthreeding females (Teklad 22/5, Preparation of tissue for freezing and histology. Injccted expeimentil and no. 8641) rodent diet: Harlan Teklad, Madison, Wis.) and tap water ad libitum.
contralateral control glands were excised and cut horizontally in halt. One halt of All mice were anesthetized by intraperitoneal injection with avertin (125 to 250 the gland was fixed in formalin, embedded in paraffin, attd cut and stained with mg/kg) and sacriliced by cervical dislocation. All procedures were approved by hematoxylin and eosin for histological purposes. The other half was cut into four the Internal Animal Care and Use Committee of the University of Colorado.
to six smaller pieces and placed in aluminum foil molds filled with embedding Adenovirus vectors. Adenovirus vectors were grown in 293 cells, which are medium (Tissue-Tek O.C.T. compound no. 4583; Sakura Finetek U.S.A., Itc, transformed by and express high levels of the adenovirus type 5 EIA and EIB Torrance, Calif.) for frozen tissue specimens. The molds were flash frozen by proteins (4) . A replication-defective adenovirus type 5 vector encoding enimmersion in an isopentane bath brought to its cooling point with liquid nitrogen. hanced. humanized, red-shifted green fluorescent protein under the control of Frozen sectioning and immunohistochemistry. Coverslips (Fisher Scientific the human cytomegalovirus major immediate-early promoter (Ad5GFP) was no. 12-544-10) were treated with BID Cell-Tak and tissue adhesive (BI) Biodescribed previously (19). sciences no. 354240), rinsed, and stored overnight at 4°C. Then 1 2 -ptn sections Virus growth. Viruses were grown in 293 cells in Dulbecco's modified Eagle's were cut from the frozen molds with it cryostat at -32'C and collected onto thte medium containing high glucose and supplemented with 10% bovine calf serum, treated coverslips. The samples were placed at 37C for I h antd fied it 2', For growth of high-titer stocks, 293 cells were infected and harvested by centrifparaformaldehyde (no. 00380; Polysciences. Inc., Warrington. Pia.) fOT I0 mrtin ugation at the time of maximal cytopathic effect, and the virus was released by After rinsing two to three times with PBS, the samples were treated withit a three cycles of freezing and thawing. Cell debris was pelleted, the supernatant blocking solution of 5% normal goat serum (#00)5-000O-121; Jackson Immunorewas saved, and the pellet was resuspended in phosphate-buffered saline (PBS), search, West Grove, Pa.) and 100 1.)g of saponin per ml (no. S4521; Sigma, St, frozen and thawed, and pelleted. The supernatant was combined with the first Louis, Mo.). Samples were rinsed twice with PBS and incubated with the approsupernatant. The pellet was resuspended in PBS and pelleted. The supernatant priate primary antibody for I h. A polyclonal antibody (7781) was made by using was combined with the prior supernatants. The supernatants were overlaid on a casein precipitated at pH 6.3 from mouse milk. Western blots showed specificity step gradient consisting of 1.25 and 1.4 g of CsCI per ml in PBS and centrifuged for mouse 13-casein. Antibody against xanthine oxidase was generated against for 50) min at 36,0(0( rpm in an SW41 rotor (Beckman). The virus band was purified mouse xanthine oxidase in rabbit and purified on protein A-Sepharose collected by side puncture, diluted with 1.35 g of CsCI per ml in PBS, and (10). For nonantibody staining, samples were treated with wheat germ agglutinin centrifuged for 3 h at 65,0(14 rpm in a VTi65 rotor (Beckman). The virus band conjugated to rhodamine (Molecular Probes; Eugene, Oreg.) to outlnec the was collected by side puncture, dialyzed for I h each against three changes of luminal surface of mammary epithelial cells, and 4',6-diamidino-2-phenvyiindole adenovirus storage buffer (10 mM Tris-HCI [pH 8.01, 135 mM NaCt, I mM (DAPI) (Sigma D-9542) diluted in PBS was used to stain for nuclei. MgCI' 2 , 5(% [vol/volI glycerol) , and stored at -20,C until use. The concentration Samples incubated with a primary antibody were rinsed live times for 5 min of virus particles was determined from the absorption at 260 nm, with I A2., unit each with PBS and treated with both donkey anti-rabbit lgG conjugated to being equivalent to 1 0t2 particles. Virus stocks were plaque titered on 293 cells. rhodamine (Molecular Probes; Eugene. Oreg.) and DAPI diluted in PBS. Both Adenovirus microinjection. Ad5GFP microinjection was performed under antibody-treated and non-antibody-treated samples were then rinsed six times avertin anesthesia at various stages of mammary gland development ( Table 1) . A for 5 min each in PBS. Then 60 gl of mounting medium (ProtLong antifade kit, stock of 2.7 X 10' PFU/ml was made in adenovirus storage buffer. Final doses no. P-7481; Molecular Probes. Eugene. Oreg.) were placed on slides (Fisher-(2,7 x 1(7 PFU for fourth mammary glands; 2 x 10" PFU for third mammary brand Superfrost. no. 12-550-15: Fisher Scientific, Pittsburgh, Pa.), and the co%-glands) were made by diluting the 2.7 x 10" PFU/ml stock with sterile filtered erslips were carefully lowered onto each slide. The slides were kept in the dairk Ringer's solution (138 mM NaCI, 8.1 itM Na 2 HPO 4 , 1.2 mM K 2 HPO 4 , 2.7 mM overnight and then placed at 4°C for storage. KHPO,, 10.9 mM CaCI 2 , 0.5 mM MgCIl). This dilution was made immediately Determination of mastitis. We developed a mastitis scoring system to exaMinc before the microinjection to ensure the stability of the adenovirus. The solution the inflammatory response in Ad5GFP-transduced mammary epithelium. Three was loaded into a 2 5-d1 Wiretrol 11 disposable glass micropipette with a stainless randomly chosen fields from hematoxylin and eosin-stained slides were assc,,sed steel plunger (no. 5-4)(0-2050; Drummond Scientific Company, Broomall, Pa.) .
by bright-field microscopy at 40x magnification from various samples fur the The end was drawn and fire-polished into a fine tip of 60 to 75 4em. By using a number of polymorphonuclear cells, mononuclear cell infiltration (scored 0. L. micromanipulator, the tip was gently inserted into the teat canal, and the solution and 2), and epithelial organization, again on a subjective scale (scored 0, 1, and was slowly ejected into the lumen of the either the third or fourth mammary 2), where I represents some mononuclear cell infiltration and epithelial disor- t4 C]sucrose was injected intraductally into the third mammary glands of nulliparous mice (VIRa and VIRb) and P17 mice at various stages after Ad5GFP injection (see Table 1 ). Each bar represents an individual mouse. Nulliparous control glands (VIR CON; n = 5) received vehicle only. The amounts of [,4C]sucrose measured in the blood after injection of PI7 control glands (noninjected; n = I1) contralateral to Ad5GFP-injected glands (Pl7inj CON) were averaged. ganization and 2 represents significant mononuclear cell infiltration and epithechose the value 4 to bring this score in line with the others. Thus, the mastitis lial disorganization, To obtain a mastitis index that provides equal weighting of score varied between 0 and 6. Three independent observers, one ol shont xtas all three measurements, we used the equation MI = P/4 + MC + EO, where MI blinded to the treatment, evaluated each slide with similar results. is the mastitis index, P is the average number of polymorphonuclear cells, MC is Microscopy and quantification of transduction. For an initial asscssment tit the mononuclear cell infiltrate, and EQ is the average epithelial organization Ad5GFP transduction, the glands were visualized under a Nikon dissecting score. Because 9 was the maximal polymorphonuclear cell count per field, we microscope under fluorescent light. Digital images were captured by using Ax- 
RESULTS
Adenovirus dosage determination. To determine the maximal dose of adenovirus vector that could be injected without incurred by the mammary epithelium at various times after induction of inflammation, various amounts of Ad5GFP were injection in a late pregnant mouse. In some cases, we evaluated injected intraductally into the fourth mammary glands of P17 the proximal, medial, and distal portions of the gland relative mice. We assessed permeability by injecting [' 4 Csucrose into the teat. As before, intraductal [i 4 C]sucrose injection was traductally and measuring its level in the blood (15, 16). Beused to measure the permeability of the mammary epithelium cause lipopolysaccharide induces massive mastitis (20), we in- (Fig. IB) , and mastitis was evaluated in hematoxylin and cosinjected it as a positive control. As the data in Fig. IA show, high stained sections ( Fig. 2A) . Figure 2A shows an L2 mammary blood levels of sucrose were associated with injection of lipogland with no detectable mastitis. An island of massive monopolysaccharide. An adenovirus dose of 10"° PFU also led to nuclear cell infiltration observed in a gland of a mouse sacrihigh sucrose permeability (Fig. IA) as well as histological signs iced on lactation day 11 (LI1), 12 days after adenovirus treatof mastitis (data not shown). Sucrose permeability was relament, is also shown in the figure. A mastitis scoring system was tively low with adenovirus doses of 10' and 109 PFU (Fig. 1A) , designed to provide a semiquantitative measure of the extent with the exception of one sample. At a dose of 10' PFU, of damage. This score, the mastitis index (measured as deepithelial permeability remained near baseline (Fig. IA) and scribed in Materials and Methods), is shown for various times the tissue showed no signs of mastitis (data not shown). A dose after injection in Fig. 3 and, in general, was not different from between 107 and 108 PFU (2.7 X 107 PFU) was determined to the index in the contralateral gland The LI0 results were conbe safe for the fourth mammary gland of the mouse. For firmed by three observers, but the [ 4 Clsucrose permeability experiments in which we used the third gland, which is about data suggest that the degree of mastitis in the Ad5GFP-inone-fifth the size of the fourth gland, we injected 2 x 10' PFU.
jected gland was small. Both the sucrose permeability data and Duration of transduction. In the next set of experiments, we the mastitis score show that an optimal dose of adenovirus used the third mammary gland to assess the amount of damage produces little damage when injected into late pregnant mice 
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and left up to 5 days or longer into lactation (Fig. 1B and 3 ). By quency of transduction. By using the DNA content of the gland L27, the gland becomes disorganized due to involutional reas a starting point, it was estimated that there were approximodeling (17).
mately 3 x 107 epithelial cells. Approximately 20%, or 6 x l)", We also examined Ad5GFP transduction in mammary of these cells were transduced in the most highly transduced glands from nulliparous mice. We found that volumes larger gland when 2 x 106 PFU of Ad5GFP were injected. The ratio than 5 p 1 burst the small ductal system in these glands (data of transducing units to PFU was near 5:1, so approximately 1)7 not shown), so all adenovirus injections were restricted to this transducing units were injected. This analysis suggests that volume. As a control, 5 p.
1 of sterile-filtered Ringer's solution greater than half of the injected vector transduced epithelial was injected into the contralateral gland. Three independent cells, supporting the idea that the process is relatively eflicient observers, one blinded, concluded that there were no gross during the late stage of pregnancy in the mammary gland. differences between the control and injected glands and that
The mammary gland consists of an inner layer of ductal cells mastitis appeared relatively minimal (data not shown). The and alveoli and an outer contractile monolayer of myoepitheextent of transduction in early pregnant and lactating glands lial cells closely attached to the basement membrane. The was very low (see below), so mastitis was not formally evalumyoepithelial cells extend laterally along ducts and form a ated in these conditions. basket-like sheath around both ducts and alveoli (13). In reExtent of adenovirus transduction. We viewed transduced sponse to oxytocin binding to specific receptors, myoepithclial mammary glands at low magnification to obtain an initial ascells contract and expel milk from the alveoli into the ducts and sessment of the amount of Ad5GFP transduction (Fig. 2B, eventually out of the gland. The presence of GFP in myocpiupper panel, and 2C). Although transduction appeared to be thelial cells in glands transduced in late pregnancy (Fig. 2D ) concentrated in areas proximal to the teat or in the middle of suggests that viral particles were able to traverse the paracelthe gland in most nulliparous and pregnant animals, some lular compartments of the mammary gland or that some myoglands did exhibit widespread transduction, as shown in Fig. 2B epithelial cells were exposed at the luminal surface. The presand 2C (upper panels). We assessed mammary sections from ence of GFP in myoepithelial cells also raises the possibility pregnant and lactating mice by using a 20X confocal view of that the basolateral surface of the mammary epithelium is 12-pim-thick frozen sections, first counting the proportion of accessible during late pregnancy, when the paracellular spaces ducts and alveoli that showed some transduction (Fig. 2B , are open to large molecules, allowing adcnovirus access to its lower panel). This analysis showed that many but not all alvereceptor (1, 23, 27 ). olar structures were transduced. Less than 10% of the ductal Epithelial structures of nulliparous mice can also be transand alveolar structures of glands from early pregnant mice duced by Ad5GFP ( Fig. 2C and 4B) . Portions of the gland showed some transduction, while approximately 30 to 50% of proximal to the teat were highly transduced after injection with the structures were transduced when the virus was injected in relatively high doses of virus, but the extent of transduction was glands from late pregnant mice (Fig. 4A) . Very low transducgreatly reduced with decreasing doses (Fig. 2C and 4B ). It is tion was achieved in glands from Ad5GFP-injected lactating possible that adenovirus transduction can be used expcrimcnmice (Fig. 4A) .
tally in nulliparous animals with small volumes and careful To further investigate the extent of alveolar transduction, we attention to optimizing the dose. used the masking function of Slidebook (see Materials and Functional competence of transduced cells. The data preMethods). By using glands injected at P17 and sacrificed on sented to this point show that mammary epithelial cells can be day 2 of lactation, we were able to delineate specific cellular transduced with Ad5GFP during pregnancy and can be mainareas of transduction and calculate the proportion of total tained well into lactation without inflammation. However, in epithelium transduced in each alveolar structure. With this order to utilize adenovirus microinjection as an eflective approach, we found that the percentage of transduced epithemethod of changing gene expression, transduced cells must lium was highly variable between two different mice (data not retain functional integrity. Two distinct pathways of cellular shown). For example, approximately 25% of the total epithemilk synthesis, milk protein secretion and milk fat secretion, lium was transduced at this stage of mammary gland developcan be assessed morphologically. Transduced alveoli displayed ment in areas proximal to the teat in one animal, and only 7% normal morphology, produced and secreted milk fat globules. of the total epithelium was transduced in the same area in and were laden with milk, which was stained red in the lumen another mouse. Areas medial and distal to the teat had lower of the alveoli in Fig. 5A . Casein, a milk protein, was also percentages of total transduced epithelium that also varied produced and was detected in the lumen of transduced alveoli greatly between animals (data not shown). (Fig. 5B ). Xanthine oxidase has been shown to redistribute To get an approximate measure of the efficiency of transfrom the cytoplasm to the surface of emerging milk fat globules duction, an estimation of the number of epithelial cells in the during pregnancy at the onset of lactation, and this rcdistrihuthird mammary gland was made and compared with the fretion is thought to be essential for milk fat globule release 0. 
McManaman, personal communication). This localization of
Ad5GFP does not disrupt normal mammary epithelial cell xanthine oxidase was maintained in transduced cells (Fig. 5C morphology and function (Fig. 5) . Adenovirus transduction did and 5D). Thus, the transduced cells appeared to be fully funcnot disrupt either of two major and distinct synthetic pathways tional.
for cellular milk secretion, milk protein secretion and milk fat globule formation. These data clearly show that adenovirus DISCUSSION transduction can be used to alter gene expression and to study luminal cell function in the mouse mammary epithelium. Adenovirus vectors have been used to transduce a variety of Adenovirus vectors used in sufficient amounts to efficiently organs in a number of animal species. Mice have been espetransduce target tissues generally induce a strong inflammatory cially popular as models to study the effects of adenovirus response that typically reaches a high level within 4 to 7 days of vectors. Intraductal injection of adenovirus vectors provides a vector introduction in a variety of immunocompetent mouse versatile method of altering gene expression in both the lumistrains. Inflammation occurs within targeted organs transduced nal and, to some extent, the myoepithelial cells of mouse mamvia the bloodstream, such as the liver (25), as well as when the mary glands. In no case did we find transduction in the intermucosal surface of an organ is targeted, such as in the lung stitial spaces of the mammary glands that we studied. It is (26). The inflammatory response both limits the duration of possible to transduce nufliparous glands (Fig. 2C and 4B) , even expression and leads to an immune response that limits sucthough these glands are immature compared to late pregnant cessful reuse of the vector. The relatively rapid induction of glands and are particularly smaller in size. Although adenoviinflammation has limited the usefulness of adenovirus vectors rus can be used to transduce the epithelium at any stage of for studies of altered gene expression in most tissues. Thus. the mammary gland development except lactation, the technique findings presented here are somewhat surprising. has proven to be most effective during the switch from pregIt is not clear why the induction of inflammation is delayed nancy to lactation (Fig. 2B, 3 , 4A, and 5A). Little mastitis was when adenovirus vectors are used in sufficient amounts to observed up to a week to 10 days after transduction with an transduce a significant fraction of the mammary epithelium. It optimal dose of virus ( Fig. 1 and 3 ). The extent of transduction is possible that this delay is due to the use of outbred CD-t was highly variable within regions of the gland relative to the mice. Adult CD-1 mice have been successfully transduced for teat and may not generate enough material for biochemical extended periods of time with adenovirus vectors (22), and analysis of transduced cells. Nevertheless, morphological studneonatal CD-1 mice did not exhibit inflammation after injecies may still be possible with neighboring nontransduced cells tion with an adenovirus vector (21), raising the possibility that as controls.
CD-1 mice may exhibit reduced inflammatory and immune We had less success with adenovirus transduction at other responses to adenovirus vectors relative to other mouse strains. stages of mammary gland development. Transduction during Alternatively, it may be that pregnancy reduced the immunoearly pregnancy was relatively low (Fig. 4A) , possibly because competence and inflammatory response of the mice. Regardthe epithelium is turning over rapidly at this developmental less, the delayed onset of inflammation means that adenovirus stage (2) . Transduction during lactation (Fig. 4A ) was rarely vectors can be effectively used as a tool for altering gene successful. Our laboratory has previously shown that tight juneexpression in the mammary gland of CD-1 mice. tion permeability is very low during lactation (16), preventing
The usefulness of first-generation adenovirus vectors in solute passage through the paracellular pathway to the basal transduction of the mammary epithelium of late pregnancy surface of the gland, where the adenovirus receptor may be means that it is not necessary to undertake the substantial localized (23, 27) There is also evidence that the coxsackie and efforts required for the use of helper-dependent, or -'gutless." adenovirus receptor is a component of the tight junction comvectors. However, it remains a possibility that the use of seeplex and that its localization within this complex impedes viral ond-generation vectors made replication incompetent through transduction (3) . deletion of a viral gene essential for viral DNA replication, Taking these factors into consideration, it is possible that the such as the terminal protein gene (11), will lead to a reduction change in tight junction permeability that accompanies secrein the low level of inflammation or extend the time prior to the tory activation is responsible for the low efficacy of adenovirus appearance of inflammation, extending their usefulness. Since transduction during lactation. Also, during lactation, the high such vectors are relatively easy to construct and grow. it may be concentration of milk proteins may adsorb the viral particles, worthwhile to test their effectiveness in transducing the mainThe density of adenovirus receptors may also differ at different mary epithelium. stages of mammary gland development with changes in endoIntraductal microinjection of adenovirus vectors should aid crine state, and these differences may influence the efficacy of in studies of a variety of genes of interest in the mammary adenovirus transduction (7) . Thorough investigations with such epithelium. Since adenovirus transduction appears to be contechniques as in situ hybridization and adenovirus receptor fined to the mammary epithelium, these methods provide a density studies in mouse mammary glands at various stages of technique to target genes of interest to this tissue compartdevelopment are needed to properly address these issues. Nevment. Potentially, these techniques could be used for drug. ertheless, adenovirus vectors appear to be effective in mediathormone, or protein delivery to milk on a short-term basis. ing the transduction of functional genes into mouse mammary Currently, our laboratory is preparing to use the methods deepithelial cells, particularly ain late pregnancy, when the tight scribed here to examine the regulation of milk synthesis and junctions between epithelial cells are open to the passage of secretion in the mouse mammary epithelium. Recombinant large molecules (15). adenovirus constructs could potentially target genes responsiOur results also demonstrate that transduction with ble for certain types of breast cancers. The procedures de- 
Summary
Claudins are normally associated with the tight junctions of epithelial cells where they confer a variety of permeability properties to the transepithelial barrier. We examined the developmental expression and localization of claudin 7 in the murine mammary epithelium. The molecule is constitutively expressed in the mammary epithelium at all levels of development and the ratio of its mRNA expression to that of keratin 19 was nearly constant. By immunohistochemistry at all developmental stages claudin 7 was located in the basolateral part of the cell where it was found in discreet cytoplasmic spots presumably representing vesicles and at the cell border. At high magnification no colocalization with the tight junction protein, ZO 1 could be observed. We confirmed the basolateral localization of claudin 7 in the airway epithelium and some types of renal tubules where cytoplasmic vesicles were also observed. That claudin 7 can associate with tight junctions was shown by its colocalization with the tight junction scaffolding protein, ZO1 in EPH4 cells, a normal murine mammary cell line, and in the epididymus.
It was also localized in the cytoplasm of MMTV-neu murine mammary tumors as well as in the transplantable murine tumor cell lines, TM4, TM10 and TM40A, where its ratio to cytokeratin was higher than in the normal mammary epithelium. Our observations suggest that claudin 7 may function in mammary epithelial cells to regulate vesicle trafficking to the basolateral membrane or stabilization of cytoplasmic vesicles.
Introduction
The claudins comprise a large family of tetraspanin membrane proteins thought to be the major barrier forming proteins of tight junctions, the cell-cell contacts at the apical border of epithelial cells that control the paracellular movement of solutes. These proteins are highly conserved with four transmembrane domains and two hydrophobic extracellular loops; the latter are thought to mediate cell-cell adhesion (Kubota et al., 1999) and to confer specific paracellular permability properties on cell monolayers (Colegio et al., 2002 (Colegio et al., , 2003 . Claudin 7 shares the general structural characteristics of the family, differing primarily in its N-terminal cytoplasmic tail (Morita et al., 1999) . The molecule has been shown to be associated with epithelial cells in the human breast (Kominsky et al., 2003) and its loss is associated with some breast and head and neck malignancies (Al Moustafa et al., 2002; Kominsky et al., 2003) . It has been shown to be expressed in parts of the renal tubule (Li et al., 2004) and the airway epithelium (Coyne et al., 2003) ,
where it is localized to the basolateral aspects of the cells. Here we show that claudin 7 is constitutively present in the epithelium of the murine mammary gland, again localized, not to tight junctions, but to punctuate structures at or near the basolateral surfaces of the cells. It was present at all cell borders of several murine mammary tumors. However, the protein can localize to tight junctions, as shown by its colocalization with ZO 1 in cultured mammary epithelial cells and epidydimus, suggesting a possible dual function depending on tissue type.
Materials and Methods
Animals and Tissue preparation.
CD - 
Real time PCR protocol.
For real time RT-PCR RNA was purifed using the Quiagen system; 1 ug DNAase treated RNA was used for each reaction. Triplicate tissue samples were assayed in duplicate using the ABI Prism 7700 sequence detection system with lung as the positive control.
Primer sequences: Murine Claudin 7, Forward CGAAGAAGGCCCGAATAGCT (338 -337); reverse GCTACCAAGGCAGCAAGACC (407 -388); probe GCCACAATGAAAACAATGCCTCCAGTCA (359-386). Murine cytokeratin:
forward, TTTAAGACCATCGAGGAC, reverse TCATACTGACTTCTCATCTCAC.
Immunohistochemistry and digital confocal microscopy.
Rat anti-mouse ZO I antibody was obtained from Chemicon International, Inc., Temecula, CA. Tissue sections, cut at 10 gim, from frozen blocks on a Damon/IEC division minotome set at -18 to -20 0 C. Sections were collected onto Cell-Tak coated coverslips and were further vapor-fixed with paraformaldehyde for 15 minutes. Sections were never allowed to dry. PBS was carefully added so as not to disrupt the sections.
Tissue was permeabilized with 1% Triton X100 for fifteen minutes, rinsed well with PBS and blocked with sterifiltered, 10% normal donkey serum for 20 minutes. All antibody solutions were microfuged for 20 minutes prior to use. The claudin antibody was diluted 1:1000. Primary incubations were for an hour at room temperature, followed by extensive washes in PBS, generally six times five minutes each. Secondary antibodies were diluted according to manufacturer's instructions, in PBS alone. The host species of all secondary antibodies was donkey and all secondary antibodies were cross-adsorbed against mouse serum proteins. Antibodies used were conjugated to fluorescein, CY3 or CY5. Secondary antibodies were combined with 0.6 gig/ml DAPI, and incubated on the tissue for an hour. Coverslips were rinsed briefly and allowed to soak overnight in PBS.
Images were collected using SlideBook software (Intelligent Imaging Innovations, Inc., Denver, CO) on a Nikon Diaphot TMD microscope equipped for fluorescence with a Xenon lamp and filter wheels (Sutter Instruments, Novato, CA), fluorescent filters (Chroma, Brattleboro, VT), cooled CCD camera (Cooke, Tonawanda, NY) and stepper motor (Intelligent Imaging Innovations, Inc., Denver, CO). Multi-fluor images were merged, deconvolved, and renormalized using SlideBook software.
Results
Developmental expression of Claudin 7 mRNA in the mammary gland. At late involution, day 29, claudin 7 expression was lower than that of keratin 19, possibly having to do with the types and characteristics of epithelial cells present during late glandular remodeling. In situ hybridization with 35 S labeled RNA probes to claudin 7 showed that the mRNA was localized to the epithelium in virgin, pregnant and lactating animals ( Fig. 1 B) . We conclude that, in the normal mammary gland, claudin 7 is confined to the epithelial compartment and is expressed at approximately constant levels through development. The very large changes in tissue expression levels during pregnancy most likely reflect an increase in epithelial cell number as the mammary epithelium expands from a system of sparse ducts in the virgin gland, to a dense mass of lactating cells in a gland where the adipose tissue is largely obliterated. We made and characterized an affinity purified antibody to the cytoplasmic tail of claudin 7 (see Methods) that proved satisfactory for both Western blots and immunohistochemistry on both frozen and paraffin sections (Fig. 2) . Given the wellknown association of claudins with tight junctions, we were surprised to find that claudin stained the basolateral region of mammary cells in all stages of development (Fig. 2) . A ductal structure surrounded by adipose stroma is shown from a virgin animal; alveoli from the glands of pregnant and lactating animals are also shown (Fig. 2B) . Staining was blocked when the antibody was preabsorbed with the claudin-7 peptide against which it was made ( 
Claudin 7 localization in other cell types
Sukumar and colleagues (Kominsky et al., 2003) reported that claudin-7 was localized to tight junctions of the human mammary carcinoma cell line, MCF-7, using an antibody directed toward the cytoplasmic tail of the human protein which differs by one amino acid from the mouse protein. We therefore examined claudin-7 staining in the normal mouse mammary cell line, EPH4 (Matsuda et al, 2004; Reichmann et al, 1992) comparing its distribution with that of ZO I (Fig. 3A) . Claudin 7 distinctly colocalizes with ZO-1 with a slightly less compact distribution. A scattering of cytoplasmic vesicles can also be seen. This finding clearly indicates that claudin 7 is capable of localizing to tight junctions, a conclusion supported by claudin 7 distribution in the epidydimus (Fig.   3B ) where claudin-7 colocalized with ZO-1 at the apical borders of some cells, but not others. Punctate cytoplasmic stain for claudin-7 can also be observed in some cells.
Claudin-7 mRNA was reported in lung and kidney, with liver being negative (Morita et al., 1999) . We therefore examined these tissues as well, finding that claudin 7
was present in cells lining bronchiolar structures of the lung where its distribution was mainly cytoplasmic as observed previously (Coyne et al., 2003 ; Fig. 3C ). However, careful examination of a black and white image at the highest magnification in the luminal cells of this structure shows some claudin-7 to be colocalized with ZO-1, suggesting that it may also be associated with tight junctions in these cells. There was no stain in the pulmonary alveoli. In the renal cortex we found claudin 7 localized only to certain segments, identified as connecting tubules and cortical collecting ducts by Li et al (Li et al., 2004) , where stain was distinctly basolateral (Fig. 3D ). Since our antibody is different from the one used by Li et al., our finding confirms this localization. At high magnification the stain is punctate as in the mammary and airway epithelia. No specific claudin 7 stain was observed in the liver (Fig. 3E ). These findings indicate that claudin 7
is capable of localizing to tight junctions as in cultured mammary epithelial cells and epidydimus, but in mammary gland, airway and kidney it is mostly or entirely confined to punctate cytoplasmic structures, often near the basolateral surfaces of the cells and possibly associated with the basolateral membranes. In no tissue was the protein observed in nuclei.
Claudin 7 localization in mammary tumors.
We examined four types of mammary tumors: tumors arising in the transgenic mouse expressing the Erb2 receptor under the control of the mammary tumor virus promoter (Guy et al., 1992) and three transplantable tumors obtained from the laboratory of Daniel
Medina (Medina et al., 1993) . All expressed claudin 7 mRNA at levels no more than 2-fold higher than the lactating mammary gland when normalized to ribosomal RNA ( (Fig. 4B) . None of these tumors demonstrated ZO1 staining indicating that they lack tight junctions, so that the claudin 7 observed here is likely associated with membrane vesicles and possibly basolateral membranes as in the normal cells of the mammary gland. Sukumar and her colleagues (Kominsky et al., 2003) observed a loss of claudin 7 expression in some human tumors, particularly lobular tumors. However, this finding was not true of the mouse mammary tumors examined.
Discussion
We find claudin 7 to be a constitutive component of luminal mammary epithelial cells,
where it is localized to the basolateral regions of the cell. The finding that the ratio of its mRNA to that of keratin 19 is relatively constant throughout the developmental cycle, Traurig, 1967) . In both studies labeling decreased after pregnancy day 5 but remained around 10% almost to parturition, consistent with the continued increase in both claudin 8 and keratin mRNA up to P 18.
Our findings are consistent with images of claudin staining in the human mammary gland where a diffuse diaminobenzidene (DAB) stain from alkaline phosphatase localization was present throughout the cytoplasm (Kominsky et al., 2003) .
However, in that study no attempt was made to localize claudin-7 stain with tight junction components. Basolateral localization of other claudins has been observed.
Claudin 1 was similarly localized in the epidydimus (Gregory et al., 2001) , intestine (Walsh et al., 2001 ) and cornea (Ban et al., 2003) , and we have observed claudin 1 both associated with tight junctions and basolaterally distributed in the luminal epithelium of the mouse mammary gland (unpublished data). Rahner et al. (2001) observed claudins 3, 4 and 5 to be laterally distributed in various portions of the gastrointestinal tract. The finding that claudin 7 is exclusively located in non-tight junction regions of mammary and renal epithelial cells (Li et al., 2004) , suggests that claudins may have functions other than regulation of tight junction permeability. Our images appear to be the first to show claudin 7 stain at sufficiently high resolution to show punctate cytoplasmic stain in mammary, airway and renal epithelial cells. Even at this resolution, obtained with digital confocal imaging with a resolution of about 200 nm, it is not possible to discern with certainty whether claudin 7 is inserted into the convoluted basolateral membranes of these cell types. If so, it is possible that the cytoplasmic spots represent vesicles on route to and from to these membranes, where claudin 7 may interact with components of the extracellular matrix. As a precedent, claudin 11, an oligodendrocyte protein has been shown to interact with a I1-integrin and to regulate proliferation and migration of oligodendrocytes in culture (Tiwari-Woodruff et al., 2001 ). Other possibilities are that vesicular claudins could regulate tight junction permeability by sequestering tight junction regulatory molecules away from tight junctions, or they could be involved in the stabilization of specialized vesicle compartments within the cytoplasm. Matsuda and colleagues, using time lapse photography show that claudin containing cytoplasmic vesicles can originate from the tight junctions as the epithelial layer remodels (Matsuda et al, 2004) . However, since claudin 7 is never observed associated with tight junctions in mammary epithelial cells, it seems unlikely that claudin 7 containing vesicles originate from the junctional complex in this tissue. Unfortunately, our mammary epithelial cell model, EPH4 cells, does not possess a heavy complement of cytoplasmic vesicles, so that live cell imaging studies will need to be carried out in the animal, to determine the origin and disposition of claudin 7 containing vesicles. It is possible that the function of the vesicles could be better assessed from analysis of the composition of the claudin 7 containing cytoplasmic vesicles.
Claudin 7 expression was inversely correlated with histological grade in a large series of breast tumors (Kominsky et al., 2003) . These same authors found, similar to our observations with EPH4 cells, that claudin 7 colocalized with ZOl in MCF7 breast cancer cells and could also be observed in cytoplasmic spots. It was present in luminal cells of the human breast, where the DAB staining appears to be localized to basolateral membranes, although in the absence of an apical marker like ZO I, it is difficult to draw a firm conclusion. An image of ductal carcinoma in situ (DCIS) in that paper shows a distribution of stain remarkably similar to that of the TM 10 tumor shown in Figure 4B .
This tumor line has been shown to have a ductual morphology (Medina et al., 1993 ).
Thus we conclude that low grade breast carcinomas show a cellular distribution of stain similar to that observed in the murine tumors. Interestingly, the murine tumors showed The claudins are represented by a large family of membranes proteins usually associated with tight junctions. Expression of one particular isoform of claudins, i.e., claudin 7, has been associated with breast tumors (Nacht M, Ferguson AT, Zhang W, et al. Cancer Res 1999; 59:5464-5470) . We have examined claudin-7 expression in mouse mammary tumors and during the development of the normal mammary gland using real time RT-PCR. We found that claudin 7 mRNA is increased more than 300 fold in early pregnancy, remained constant during lactation and was down-regulated at involution when compared to total RNA in the gland. However, the ratio of claudin 7 to an epithelial cell marker, cytokeratin-19 remained nearly constant through development suggesting that claudin-7 is a constitutive component of mammary epithelial cells. This hypothesis was confirmed by in situ localization of the mRNA to the mammary epithelium in mammary glands from virgin, pregnant and lactating mice as well as the finding that it was expressed in all the mouse mammary tumors examined. In contrast claudin 3 was highly expressed during pregnancy and claudin 8 was significantly expressed only during lactation. Immunolocalization of claudin 7 in the normal mammary gland produced the surprising result that claudin-7 does not overlap with a marker of tight junctions, ZO-1, but rather appeared to be present in vesicles associated with both lateral and basal membranes of the cell. Claudin 1, on the other hand was localized to tight junctions in the epithelium of the virgin gland. Claudin 7 was localized to tight junctions in cultured mammary epithelial cells and the epididymus, but not the lung where it was also highly expressed. These findings suggest that claudin 7 is not involved in tight junctions in the mammary gland or lung but may be involved in interactions of these cells with the extracellular matrix. (Supported by DOD grant DAMD17-01-1-0211 to MCN). in the gland. However, the ratio of claudin 7 to an epithelial cell marker, cytokeratin-19 remained nearly constant through development suggesting that claudin-7 is a constitutive component of mammary epithelial cells. This hypothesis was confirmed by in situ localization of the mRNA to the mammary epithelium in mammary glands from virgin, pregnant and lactating mice as well as the finding that it was expressed in all the mouse mammary tumors examined. In contrast claudin 3 was highly expressed during pregnancy and claudin 8 was significantly expressed only during lactation. Immunolocalization of claudin 7 in the normal mammary gland produced the surprising result that claudin-7 does not overlap with a marker of tight junctions, ZO-1, but rather appeared to be present in vesicles associated with both lateral and basal membranes of the cell. (Figure 1 ) Claudin 1, on the other hand was localized to tight junctions in the epithelium of the virgin gland. Claudin 7 was localized to tight junctions in cultured mammary epithelial cells and the epididymus, but not the lung where it was also highly expressed. Conclusions: These findings suggest that claudin 7 is not involved in tight junctions in the mammary gland or lung but may be involved in interactions of these cells with the extracellular matrix. 
